-
Nagi Bioscience together with Bayer CropScience at the prestigious 2022 SOT Annual Meeting in San Diego
Our CSO and co-founder Laurent Mouchiroud will present Nagi’s pioneer technology used in a successful project for Bayer CropScience at the prestigious SOT Annual Meeting.
-
Nagi Bioscience at TechTour Future22
Meet the first Organism-on-Chip technology on Friday 25th March at 14:30 CET at the TechTour Future22 event.
-
The SERI-funded EIC Accelerator program grants Nagi Bioscience with €2.5 million to accelerate development and commercial scale-up of their unique ‘Organism-on-Chip’ product
Professing the transition to the new era of biological testing as our vision, being selected by the EIC Accelerator program is going to be crucial to make Nagi’s vision a reality.
-
Alternative Testing Methods
The new biotech horizon with an expected 10% annual growth from 2022 to 2025.
-
Meet our new Team Members!
The revolution of innovative and ethical biological testing counts today with three new talents!
-
The C. elegans Nobel Prizes
Learn more about the Nobel Prizes that were awarded to C. elegans researchers.
-
How C. elegans can bridge the gap between cells and mouse
How c. elegans can be a sustainable and cost-effective solution bridging the gap between cells and vertebrates.
-
Nagi’s team is growing!
Our Nagi Bioscience’s team is expanding! We welcome Alexandre Vaudano, who will be working as an Intern in charge of Business Development and Marketing.
-
W.A. De Vigier Stiftung startup competition finalist
Nagi Bioscience was selected as a finalist of the prestigious W.A. De Vigier Stiftung startup competition in 2021.
-
Nagi Bioscience was selected as part of the EU funded “HealthAge” project
Nagi Bioscience was selected as part of the EU-funded “HealthAge” project.